Drug Profile
CM 1212
Alternative Names: CM-1212Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator CureMark
- Developer Curemark
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alcoholism; Substance-related disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Alcoholism in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Substance-related disorders in USA
- 27 Nov 2012 Preclinical trials in Alcoholism in USA (unspecified route)